Filing Flows › Comparisons › ADCT vs RAPP
ADC Therapeutics SA vs Rapport Therapeutics: ADCT and RAPP compared
ADC Therapeutics SA is the larger company: $21.7M of revenue in its latest quarter (Q3 2026) against $20.0M for Rapport Therapeutics (Q1 2026). ADC Therapeutics SA is more profitable, with an operating margin of -66.1% against -121.1%.
Where the money goes: ADCT and RAPP
ADC Therapeutics SA (ADCT) · Q3 2026
ADC Therapeutics SA, Q3 2026: revenue $21.7M (+32% year over year), operating margin -66.1%, net loss $25.3M. The chart follows the revenue to costs, profit and cash.
Rapport Therapeutics (RAPP) · Q1 2026
Rapport Therapeutics, Q1 2026: revenue $20.0M, operating margin -121.1%, net loss $19.9M, operating cash flow −$13.1M. The chart follows the revenue to costs, profit and cash.
| ADC Therapeutics SA (ADCT) | Rapport Therapeutics (RAPP) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 2026 |
| Revenue | $21.7M | $20.0M |
| Revenue growth, Y/Y | +32% | — |
| Operating margin | -66.1% | -121.1% |
| Net earnings | −$25.3M | −$19.9M |
| Net margin | -116.5% | -99.3% |
| Operating cash flow | — | −$13.1M |
Where the revenue comes from
ADC Therapeutics SA
- Product revenues, net: $21.0M (97%)
- License revenues and royalties: $710K (3%)
Questions
Which is bigger, ADC Therapeutics SA or Rapport Therapeutics?
ADC Therapeutics SA is the larger company: $21.7M of revenue in its latest quarter (Q3 2026) against $20.0M for Rapport Therapeutics (Q1 2026).
Is ADC Therapeutics SA or Rapport Therapeutics growing faster?
ADC Therapeutics SA is more profitable, with an operating margin of -66.1% against -121.1%.
More: ADC Therapeutics SA earnings · how ADC Therapeutics SA makes money · Rapport Therapeutics earnings · how Rapport Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (8-K filed Nov 9, 2026; 10-Q filed May 7, 2026). Fiscal quarters can end on different dates. Not investment advice.